Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Notes Payables (2016 - 2019)

Aethlon Medical filings provide 8 years of Notes Payables readings, the most recent being $892591.0 for Q2 2019.

  • On a quarterly basis, Notes Payables changed N/A to $892591.0 in Q2 2019 year-over-year; TTM through Jun 2019 was $892591.0, a N/A change, with the full-year FY2019 number at $962301.0, changed N/A from a year prior.
  • Notes Payables hit $892591.0 in Q2 2019 for Aethlon Medical, down from $962301.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $962301.0 in Q1 2019 to a low of $248367.0 in Q2 2015.
  • Median Notes Payables over the past 4 years was $749203.0 (2016), compared with a mean of $664870.4.
  • The widest YoY moves for Notes Payables: up 1831.75% in 2015, down 36.32% in 2015.
  • Aethlon Medical's Notes Payables stood at $434643.0 in 2015, then surged by 39.38% to $605815.0 in 2016, then soared by 53.84% to $932014.0 in 2018, then fell by 4.23% to $892591.0 in 2019.
  • The last three reported values for Notes Payables were $892591.0 (Q2 2019), $962301.0 (Q1 2019), and $932014.0 (Q4 2018) per Business Quant data.